Abstract
Major points of controversy identified by the workshop included: (i) symptom assessment of acid-related disorders in children, where vomiting was identified as a potential confounding feature, abdominal pain as a common feature of paediatric gastro-oesophageal reflux disease; (ii) extra-oesophageal manifestations of paediatric gastro-oesophageal reflux disease; (iii) abdominal pain perceived as a common feature of Helicobacter pylori-related disorders; (iv) role of testing for H. pylori in children; (v) test-and-treat strategies for H. pylori infection in children before long-term proton pump inhibitor therapy; (vi) an underutilization of triple therapy and proton pump inhibitors in children in areas with a high prevalence of H. pylori infection; (vii) the role of empiric proton pump inhibitor therapy in children.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Alimentary Pharmacology & Therapeutics Symposium Series
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
